about
Optimizing the data combination rule for seamless phase II/III clinical trials.What inference for two-stage phase II trials?Statistical inference for extended or shortened phase II studies based on Simon's two-stage designsSequential design of phase II-III cancer trials.Minimax and admissible adaptive two-stage designs in phase II clinical trials.Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints.Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.Optimal adaptive two-stage designs for early phase II clinical trials.Decision-theoretic designs for small trials and pilot studies: A reviewProper inference from Simon's two-stage designs.Designing clinical trials for dystonia.Clinical trial design in non-invasive brain stimulation psychiatric research.Boundary problem in Simon's two-stage clinical trial designs.Asymmetric inner wedge group sequential tests with applications to verifying whether effective drug concentrations are similar in adults and children.Accounting for uncertainty in the historical response rate of the standard treatment in single-arm two-stage designs based on Bayesian power functions.Adaptive sample size modification in clinical trials: start small then ask for more?An optimal stratified Simon two-stage design.Optimal Tests of Treatment Effects for the Overall Population and Two Subpopulations in Randomized Trials, using Sparse Linear Programming.Phase II design with sequential testing of hypotheses within each stage.Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation.Statistical issues in drug development.Test-compatible confidence intervals for adaptive two-stage single-arm designs with binary endpoint.Optimal adaptive two-stage designs for phase II cancer clinical trials.
P2860
Q30860286-E8DB8D2E-A81E-4760-B8C1-2F393A7DEB31Q34367748-319119F1-14DC-4F15-9145-A6164B3B0A00Q35655152-5CCEECF3-CEA6-4FDA-B775-BFDFBF19CE58Q35940107-4107B20F-76C4-4A91-B830-251D382E554CQ36093337-2C4B6453-FEF7-406D-AF77-5A284A5C2961Q36272018-39074993-A12A-4307-9532-541AFFE523E6Q36547383-D7C25D06-CB98-4C7E-B0AD-5D347EA45392Q36649834-BB57D288-8E44-4C2E-B14C-664832280627Q36925422-69BE59EA-F932-420E-9810-4448161E977DQ36981393-4213929F-AEA6-4EF6-9C3A-641B1D8516A0Q37506514-A2BDC339-3B6A-4471-8F3E-E51FDFE6F983Q37871523-18DB65BE-9CBD-4B8C-8525-F163467B00CEQ38907684-8EDAF260-6A58-491C-97E8-91066BF27BC5Q39177406-6AC14D8B-AA10-414B-ACD5-57E80B402C1DQ39263674-9C1EA88D-AF83-438B-A183-ABDF36C64B6FQ40739745-7C1A0637-B52D-4393-A43D-3EC509BE2FFAQ40877368-F7573048-03F4-4521-B616-9C2AF008C4E7Q41954439-07FF2D16-E720-42B3-96CC-6A8B301C9EE7Q43427263-1DE74BF2-754B-490F-9156-E2A971DB359DQ44385353-9191C9DF-80DA-41BD-A557-85EA244997C4Q44557252-0B73BE1F-0397-49E9-A267-6838ADE2FFAAQ48117225-48869D7C-2381-4FE6-B679-0421E6A5B34FQ51184477-9F51A352-4C0A-4FAF-B070-F835D744A316
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Adaptive two-stage designs in phase II clinical trials.
@ast
Adaptive two-stage designs in phase II clinical trials.
@en
Adaptive two-stage designs in phase II clinical trials.
@nl
type
label
Adaptive two-stage designs in phase II clinical trials.
@ast
Adaptive two-stage designs in phase II clinical trials.
@en
Adaptive two-stage designs in phase II clinical trials.
@nl
prefLabel
Adaptive two-stage designs in phase II clinical trials.
@ast
Adaptive two-stage designs in phase II clinical trials.
@en
Adaptive two-stage designs in phase II clinical trials.
@nl
P356
P1476
Adaptive two-stage designs in phase II clinical trials.
@en
P2093
Anastasios A Tsiatis
Anindita Banerjee
P304
P356
10.1002/SIM.2501
P407
P577
2006-10-01T00:00:00Z